Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration

Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration

Background. Most patients with metastatic prostate cancer are endocrinologically treated with LHRH agonist, but finally castration-refractory and hormone-refractory cancers occur. Serum testosterone levels get low to “the castration level” by LHRH agonists but may not get low enough against castrati...

Full description

Bibliographic Details
Main Authors: Masayoshi Zaitsu, Mariko Yamanoi, Koji Mikami, Yuta Takeshima, Naohiko Okamoto, Sadao Imao, Akiko Tonooka, Takumi Takeuchi
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Advances in Urology
Online Access:http://dx.doi.org/10.1155/2012/979154

Similar Items

Similar Items